Skip to main content

Market Overview

12 Health Care Stocks Moving In Friday's Intraday Session

Share:

 

Gainers

  • Novan (NASDAQ:NOVN) stock rose 71.04% to $15.46 during Friday's regular session. As of 12:30 EST, Novan's stock is trading at a volume of 109.3 million, which is 2334.72% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $234.5 million.
  • Aptinyx (NASDAQ:APTX) shares increased by 23.92% to $3.98. As of 12:30 EST, this security is trading at a volume of 22.2 million shares, making up 4644.19% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $271.1 million.
  • Vaxart (NASDAQ:VXRT) shares moved upwards by 22.3% to $8.77. As of 12:30 EST, Vaxart's stock is trading at a volume of 82.5 million, which is 521.94% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.0 billion.
  • Cassava Sciences (NASDAQ:SAVA) shares increased by 20.27% to $79.8. As of 12:30 EST, Cassava Sciences's stock is trading at a volume of 6.3 million, which is 357.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.1 billion.
  • Progenity (NASDAQ:PROG) shares rose 17.67% to $2.93. As of 12:30 EST, this security is trading at a volume of 14.6 million shares, making up 1695.57% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $177.1 million.
  • Evofem Biosciences (NASDAQ:EVFM) stock increased by 17.61% to $1.24. Trading volume for this security as of 12:30 EST is 63.1 million, which is 684.46% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $188.7 million.

 

 

Losers

 

  • Curis (NASDAQ:CRIS) stock fell 36.83% to $8.01 during Friday's regular session. Trading volume for this security as of 12:30 EST is 12.7 million, which is 437.86% of its average full-day volume over the last 100 days. The company's market cap stands at $733.2 million.
  • Galecto (NASDAQ:GLTO) shares decreased by 27.13% to $5.83. As of 12:30 EST, Galecto's stock is trading at a volume of 7.4 million, which is 2352.73% of its average full-day volume over the last 100 days. The company's market cap stands at $147.2 million.
  • Heat Biologics (NASDAQ:HTBX) shares fell 24.58% to $7.24. Heat Biologics's stock is trading at a volume of 3.9 million shares as of 12:30 EST. This is 434.96% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $182.8 million.
  • Forma Therapeutics Hldgs (NASDAQ:FMTX) stock decreased by 21.29% to $22.08. Trading volume for this security as of 12:30 EST is 530.9K, which is 130.67% of its average full-day volume over the last 100 days. The company's market cap stands at $1.1 billion.
  • Biomerica (NASDAQ:BMRA) shares fell 14.48% to $3.96. As of 12:30 EST, this security is trading at a volume of 340.9K shares, making up 116.81% of its average full-day volume over the last 100 days. The company's market cap stands at $48.7 million.
  • Equillium (NASDAQ:EQ) stock fell 14.4% to $5.97. Trading volume for this security as of 12:30 EST is 488.4K, which is 301.91% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $173.5 million.

 

 

 

Related Articles (BMRA + APTX)

View Comments and Join the Discussion!

Posted-In: BZI-TFMIntraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com